Repair levels in forskolin treated cells significantly different from vehicle at indicated time points were determined by 2-way ANOVA (*or to generate ATR-pS435 in the presence or absence of cisplatin. phosphorylation at S435 is necessary for cAMP-enhanced repair of platinum-induced damage and protection against cisplatin-induced mutagenesis. These data implicate cAMP signaling as a critical regulator of genomic stability against platinum-induced mutagenesis. Introduction There are more than fifteen million malignancy survivors in the United Says1. Platinum-based brokers are important components of a variety of multimodal CIL56 oncologic treatment regimens because they interfere with replication and DNA homeostasis by altering the structure of nucleotides and DNA. Though platinum compounds are useful in treating a variety of cancers, they promote genomic instability and mutagenesis by chemically modifying nucleic acid bases. Consequently, development of secondary malignancies is usually a well-characterized long-term risk of platinum exposure. Survivors of child years cancers are at particularly high risk for secondary malignancies because many patients survive their main cancers and there is ample latency time to develop secondary malignancies because of their young age when exposed to chemotherapy2,3. In fact, melanoma is among the most common secondary tumors among child years cancer survivors, occurring 14 occasions CIL56 more frequently than in an age-matched cohort not exposed to chemotherapy4. One retrospective meta-analysis concluded that melanoma accounts for 5.3% of all secondary cancers among survivors of pediatric malignancies, with survivors of Hodgkin disease, hereditary retinoblastoma and soft tissue sarcomas especially at risk (standardized incidence ratios of 6.7, 27.6 and 6.7, respectively)5. Since platinum-based therapeutics are commonly used to treat child years malignancies, we posit that a crucial determinant of secondary melanoma risk may be the capacity of melanocytes to repair platinum-induced DNA injury and that sub-optimal repair would favor mutagenesis and genomic instability. Hence, a greater understanding of the biochemical mechanisms that promote cisplatin-repair/resistance is important for predicting the likelihood for the development of secondary malignancies and for developing useful melanoma-preventive methods in high-risk patients. The melanocortin 1 receptor (MC1R) is usually a highly polymorphic Gs protein-coupled cell surface receptor on melanocytes6 that functions as a global regulator of melanocyte physiology and damage responses7,8. When stimulated by its agonistic ligand MSH, MC1R promotes the formation of the second messenger cAMP through activation of adenylyl cyclase9. MC1R signaling is usually impacted by a variety of ligands which regulate MC1R-cAMP responses. Agouti signaling protein (ASIP) functions as an inverse agonist for MC1R decreasing MC1R basal signaling10 while human -defensin 3 (HBD3) is usually a neutral antagonist that blunts effects of other MC1R ligands11,12. In humans, is CIL56 usually highly polymorphic with more than 70 variants, many of which impair MC1R-cAMP signaling responses13. At least five reddish hair color (RHC) single nucleotide polymorphisms (MC1R-D84E, -R142H, -R151C, -R160W, and -D294H) are associated with reddish hair, freckling, fair skin, UV sensitivity and increased lifetime melanoma risk6. We as well as others have reported that MC1R/cAMP signaling regulates melanocyte genomic stability by enhancing and accelerating nucleotide excision repair (NER)-mediated clearance of helix-distorting, replication-blocking DNA adducts generated by UV14C19. Like UV, cisplatin damages DNA in CIL56 ways that interfere with replication, transcription and genomic stability. The major effect cisplatin has on DNA is to generate intrastrand adducts by forming covalent bonds with the N7 position of adjacent purine bases to form 1,2- or 1,3-intrastrand crosslinks. Intrastrand platinum-induced DNA adducts distort the double helix and are acknowledged and removed by NER20. The xeroderma pigmentosum complementation group proteins (XPs), which include XPA through XPG, play a critical role in coordinating and promoting NER21C23. XP group A TIAM1 (XPA) deficiency exhibits among the highest UV sensitivity among XP cells24,25. Functionally, XPA is usually involved in many actions of NER including DNA damage verification, stabilization of repair intermediates and positioning NER factors appropriately at sites of action26,27. Similarly, ATR is critical to UV DNA damage signaling28 and is linked with NER29C34. Furthermore, ATR provides an anti-mutagenic role in a subset of melanomas35. We recently explained a molecular pathway linking MC1R signaling with XPA through a.